Renaissance Technologies’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-82,699
| Closed | -$7.38M | – | 3642 |
|
|
2023
Q2 | $7.38M | Buy |
+82,699
| New | +$7.38M | 0.01% | 1186 |
|
|
2020
Q3 | – | Sell |
-55,082
| Closed | -$8.15M | – | 3362 |
|
|
2020
Q2 | $8.15M | Buy |
55,082
+4,004
| +8% | +$592K | 0.01% | 1348 |
|
|
2020
Q1 | $5.75M | Buy |
51,078
+21,235
| +71% | +$2.39M | 0.01% | 1485 |
|
|
2019
Q4 | $4.15M | Sell |
29,843
-44,756
| -60% | -$6.23M | ﹤0.01% | 1970 |
|
|
2019
Q3 | $7.19M | Sell |
74,599
-105,200
| -59% | -$10.1M | 0.01% | 1603 |
|
|
2019
Q2 | $20.7M | Buy |
179,799
+91,000
| +102% | +$10.5M | 0.02% | 944 |
|
|
2019
Q1 | $10.5M | Buy |
+88,799
| New | +$10.5M | 0.01% | 1353 |
|
|
2018
Q4 | – | Sell |
-41,900
| Closed | -$2.97M | – | 3366 |
|
|
2018
Q3 | $2.97M | Sell |
41,900
-14,600
| -26% | -$1.03M | ﹤0.01% | 2086 |
|
|
2018
Q2 | $3.76M | Buy |
56,500
+49,860
| +751% | +$3.32M | ﹤0.01% | 1955 |
|
|
2018
Q1 | $434K | Sell |
6,640
-8,860
| -57% | -$579K | ﹤0.01% | 2961 |
|
|
2017
Q4 | $621K | Sell |
15,500
-18,000
| -54% | -$721K | ﹤0.01% | 2833 |
|
|
2017
Q3 | $1.21M | Buy |
33,500
+8,030
| +32% | +$291K | ﹤0.01% | 2504 |
|
|
2017
Q2 | $707K | Buy |
+25,470
| New | +$707K | ﹤0.01% | 2675 |
|